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Chapter 1: Introduction to the Developments in the Coordination Chemistry of 
Eu
2+
 
1.1 Introduction 
The divalent oxidation states of the lanthanide ions (Ln
2+
) are less stable 
compared to their well-known trivalent oxidation states (Ln
3+
). Before the 1990s, only 
Eu
2+
, Yb
2+
, and Sm
2+
 were known both in solution and in the solid state.
1–4
 The 
calculated reduction potentials (versus normal hydrogen electrode) of Ln
3+
/Ln
2+
 are 
shown in Table 1.1.
5
 As you can see, europium has the most positive reduction 
potential due to its half-filled 4f orbitals. 
Table 1.1 Calculated Ln
3+
/Ln
2+
 reduction potentials (versus normal hydrogen electrode) of 
lanthanides
5 
Ln Potential (V) Ln Potential (V) 
Eu −0.35 Pr −2.9 
Yb −1.15 Ho −2.9 
Sm −1.55 Er −3.1 
Tm −2.3 La −3.1 
Dy −2.5 Ce −3.2 
Nd −2.6 Tb −3.7 
Pm 
Lu 
−2.7 
−2.7 
Gd −3.9 
Recently, Evans and coworkers synthesized divalent lanthanide complexes 
[K(2.2.2-cryptand)][(C5H4SiMe3)3Ln] (1.1) (Figure 1.1) in which Ln includes all 
lanthanides except the radioactive element Pm.
5,6
 Among these compounds, Eu
2+
, 
2 
 
Yb
2+
, Sm
2+
, and Tm
2+
 have 4f
n+1
 ground state electronic configurations; La
2+
, Ce
2+
, 
Pr
2+
, Gd
2+
, Tb
2+
, Ho
2+
, Y
2+
, Er
2+
, and Lu
2+
 have 4f
n
5d
1
 ground state electronic 
configurations; and Dy
2+
 and Nd
2+
 also have 4f
n
5d
1
 ground state electronic 
configurations even though traditionally they were reported as 4f
n+1
.
5
 Research in the 
Evans laboratory challenged traditional thoughts that Eu
2+
, Yb
2+
, Sm
2+
, Tm
2+
, Dy
2+
, 
and Nd
2+
 are the only divalent lanthanide ions that can be isolated in molecular 
compounds.
7,8
  
 
Figure 1.1 Chemical Structure of complex 1.1. 
1.2 Properties and applications of Eu
2+
-containing complexes. 
Among the divalent lanthanides, europium has the most positive reduction 
potential (Table 1.1). Therefore, it has the most accessible divalent oxidation state. In 
its ground state, Eu
2+
 ion has seven unpaired electrons in 4f orbitals. It is isoelectronic 
with Gd
3+
 and has a faster water-exchange rate. These 4f electrons also produce a 
large spin magnetic moment of 7 µB.
9
 Eu
2+
-containing complexes have characteristic 
broad emissions (390–580 nm) in addition to sharp emission bands between 354 and 
376 nm that are similar to those observed in Eu
3+
.
10
 In protic solvents such as H2O 
and CH3OH, the luminescence of Eu
2+
 can be quenched by the O–H oscillators of 
solvent molecules in the first coordination sphere. Macrocyclic ligands are known to 
have an “insulation effect”, and they are able to enhance the emission of Eu2+ 
compared to free Eu
2+
 because of a decrease in the non-radiative rate constant.
11 
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Eu
2+
-containing complexes have considerable applications in synthetic chemistry, 
medical diagnosis, and materials science.
10
 For example, complex 1.2 (Figure 1.2) 
serves as a single-electron reductant when reacting with PhSeSePh;
12
 complex 1.3 
(Figure 1.2) that contains indenyl ligands initiates the polymerization of methyl 
methacrylate;
13
 and complex 1.4 (Figure 1.2) is found to be a more efficient MRI 
contrast agent at ultra-high field strengths than at lower fields.
14
 
 
Figure 1.2 Structures of Eu
2+
-containing complexes 1.2–1.4. 
1.3 Methods to stabilize Eu
2+
 
In spite of the greater stability compared to other divalent lanthanides, Eu
2+
 is 
easily oxidized in solution when exposed to air. The application of Eu
2+
 in solution is 
largely limited by the lack of suitable ligands to stabilize its divalent state. For 
example, while Eu
2+
 is widely used in solid-state lighting materials,
15
 its 
luminescence properties in solution are less studied due to the tendency to be oxidized 
to Eu
3+
.
11 
To take advantage of the interesting magnetic, catalytic, and luminescence 
properties of Eu
2+
, efficient methods must be developed to prevent oxidation. One 
promising way is to use macrocyclic ligands to encapsulate Eu
2+
. The Allen research 
group has studied the oxidative stability of a series of Eu
2+
-containing cryptates (1.5–
1.10) (Figure 1.3).
16
 Notably, complex 1.10 is the most oxidatively stable 
4 
 
Eu
2+
-containing complex in aqueous solution to date. It possesses an oxidative 
potential that is 35 mV more positive than Fe
2+
 in hemoglobin. The rationale for this 
design are that (1) the phenyl ring reduces the cryptand cavity size (better matching 
with the size of Eu
2+
); (2) the phenyl ring reduces the Lewis basicity of adjacent 
oxygen atoms (better for electron-rich Eu
2+
); and (3) the sulfur atoms are softer than 
oxygen atoms (better matching with soft Eu
2+
 based on hard–soft acid–base theory). 
Their study demonstrated that stabilization of Eu
2+ 
can be achieved by manipulating 
the electronic and steric properties of the coordinating ligands. 
 
Figure 1.3 Chemical structures of unfunctionalized Eu
2+
-containing cryptate 1.5 and 
functionalized Eu
2+
-containing cryptates 1.6–1.10 (coordinated water molecules and counter ions 
are not shown for clarity). 
1.4 Aims of my research 
The goal of my research was to synthesize new ligands which can stabilize Eu
2+
. 
Through fine-tuning of ligand properties, we envisioned that the resulting 
Eu
2+
-containing complexes would have applications as MRI contrast agents, 
luminescence materials, and magnetic materials. Inspired by the previous success 
using functionalized cryptands, I focused my work on modifying cryptands. The 
second chapter of this thesis discusses the synthesis of a cryptand linked with an 
5 
 
isophthalic acid through a thiourea bridge (1.11). In the third chapter, synthesis of an 
azacryptand 1.12, and progress towards synthesizing its derivative 1.13 are described. 
Ligand 1.14 in which two cryptands are bridged by tetraoxolene is discussed in the 
fourth chapter. 
 
Figure 1.4 Chemical structures of compounds 1.11–1.14. 
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Chapter 2: Synthesis of Cryptand Ligands for Eu
2+
-Containing Complexes as 
Potential Contrast Agents 
2.1 Introduction 
Magnetic resonance imaging (MRI) is a powerful technique used in medical 
diagnoses. It is non-invasive and has excellent spatial resolution.
17,18
 Most clinical 
scanners operate at 1.5–3 T, but higher field strengths provide considerable 
improvements in spatial and temporal resolution. Thus, there is a tendency in the MRI 
community to increase magnetic field strength.
19,20
 However, common T1-shortening 
Gd
3+
-based contrast agents become less efficient as field strength increases.
21,22
 The 
Allen research group has investigated Eu
2+
-containing cryptates as alternatives to 
Gd
3+
-containing complexes because Eu
2+
 is isoelectronic to Gd
3+
 with a faster 
water-exchange rate and two inner-sphere water molecules.
23,24
 These properties are 
ideal for ultra high field strength (≥7 T) MRI, and consequently, the Allen research 
group has shown that Eu
2+
-containing [2.2.2]cryptates 2.1–2.3 (Figure 2.1) are more 
effective at ultra-high field strengths than at lower fields.
14
  
Figure 2.1 Examples of Eu
2+
-containing [2.2.2]cryptates (2.1–2.3) that are more effective contrast 
agents for magnetic resonance imaging at ultra-high field strengths compared to lower fields.
14
  
However, the inherent positive charges of cryptates 2.1–2.3 might limit their 
applications. Srinivasan and Sawyer indicated that the blood vessel wall and blood 
cells are negatively charged under normal conditions.
25
 Thus, positively charged 2.1–
7 
 
2.3 might interact with the blood vessel walls and blood cells and hinder their in vivo 
delivery. Based on this idea, ligand 2.4 was designed in which the cryptand ring and 
isophthalic acid are joined together by a thiourea linker. The rationale for this ligand 
is that, upon metalation with Eu
2+
, it will produce a neutral complex 2.5 that will have 
a low tendency to interact with blood vessel walls and blood cells (Scheme 2.1). 
Scheme 2.1 Metalation of 2.4 to form neutral Eu
2+
-containing complex 2.5. 
 
Initially, I synthesized cryptand 2.6 (Scheme 2.2), which contains two methyl 
ester groups instead of two carboxyl groups, because dimethyl 
5-isothiocyanatoisophthalate is commercially available. However, neither acid nor 
base hydrolysis of 2.6 produced the desired product 2.4. I then prepared 
5-isothiocyanatoisophthalic acid (2.7) by following a published procedure.
26
 This 
effort afforded cryptand 2.4. The synthetic procedures of cryptand 2.4 and 2.6 are 
same except for the last step (Scheme 2.2). Compounds 2.8–2.11 were prepared using 
similar methods to those described by Gansow and coworkers.
27
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Scheme 2.2 Synthesis of cryptands 2.4 and 2.6. 
 
2.2 Experimental Procedures 
2.2.1 Materials 
Commercially available chemicals were of reagent-grade purity or better and 
were used as received unless otherwise noted. Triethylamine was dried over calcium 
hydride and distilled under an argon atmosphere. Water was purified using a 
PURELAB Ultra Mk2 purification system. Flash chromatography was performed 
using silica gel 60, 230–400 mesh. Analytical thin-layer chromatography (TLC) was 
carried out on TLC plates precoated with silica gel 60 F254 (250 μm layer thickness). 
TLC plates visualization was accomplished with a UV lamp or by charring with 
9 
 
potassium permanganate stain (1.5 g KMnO4, 10 g K2CO3, 2.5 mL 5% w/v aqueous 
NaOH, and 150 mL H2O). 
2.2.2 Characterization 
1
H- and 
13
C-NMR spectra were recorded at ambient temperature on a Varian 
Unity 400 spectrometer (400 MHz for 
1
H and 101 MHz for 
13
C). Chemical shifts were 
referenced to solvent residual signals (CDCl3: 
1H δ 7.26 ppm, 13C δ 77.16; CD3CN: 
1H δ 1.94, 13C δ 118.26, 1.32; DMSO-d6: 
1H δ 2.50, 13C δ 39.52; D2O: 
1H δ 4.79, 13C 
was referenced to 5% DMSO-d6 added δ 39.52; CD2Cl2: 
1H δ 5.32, 13C δ 53.84). 
1
H-NMR data are assumed to be first order, and the apparent multiplicities are 
reported as follows: „„s‟‟ = singlet, „„d‟‟ = doublet, “t” = triplet, „„dd‟‟ = doublet of 
doublets, “m” = multiplet, and „„br‟‟ = broad. Italicized elements are those that are 
responsible for the shifts. High resolution electrospray ionization mass spectra 
(HRESIMS) were recorded on a Waters LCT Premiere Xe TOF mass spectrometer. 
Low resolution mass spectra (MS) of known compounds were recorded on a 
Shimadzu LCMS-2010EV mass spectrometer. 
2.2.3 Synthesis 
5-Isothiocyanatoisophthalic acid (2.7): Compound 2.7 was synthesized according to 
the literature procedure.
26
 5-Aminoisophthalic acid (2.12 g, 11.7 mmol, 1 equiv), 
sodium acetate trihydrate (6.83 g, 50.2 mmol), and NaOH (1.05 g, 26.2 mmol) were 
dissolved in a mixed solvent of water (50 mL) and acetone (25 mL) while stirring. 
The resulting solution was cooled to 0 °C. Thiophosgene (1.50 g, 13.0 mmol, 1.1 
equiv) was added to the cold solution in one shot. A yellow suspension formed, and it 
10 
 
turned into a white cloudy mixture after 30 min. After stirring for 2 h, concentrated 
HCl was added dropwise to adjust the pH of the reaction to 3. The crude product 
precipitated as a white solid. The solid was isolated by filtration using a medium 
porosity glass frit and washed with 0.1 M hydrochloric acid (3 × 10 mL). Acetone 
(100 mL) was added and the soluble part was isolated and concentrated under reduced 
pressure to yield 1.05 g (40%) of 2.7 as white powder. 
1
H- and 
13
C-NMR spectra
 
were 
assigned by comparison with literature.
26
 
1
H NMR (400 MHz, DMSO-d6) δ 13.63 (brs, 
2H), 8.37 (t, J = 1.5 Hz, 1H), 8.08 (d, J = 1.5 Hz, 2H); 
13
C NMR (101 MHz, 
DMSO-d6) δ 165.4, 136.2, 133.1, 131.4, 130.2, 128.6; MS (m/z): [M − H]
−
 calcd for 
C9H4NO4S, 222.0; found, 222.0. 
Dimethyl 2,2'-((4-nitro-1,2-phenylene)bis(oxy))diacetate (2.8): Compound 2.8 was 
prepared using similar methods to those described by Gansow and coworkers.
27
 To a 
stirred mixture of anhydrous K2CO3 (5.40 g, 39.1 mmol, 3 equiv) in acetone (100 mL) 
was slowly (over 30min) added methyl bromoacetate (5.98 g, 39.1 mmol, 3 equiv) at 
ambient temperature. A solution of 4-nitrocatecol (2.06 g, 13.3 mmol, 1 equiv) in 
acetone (30 mL) was added dropwise to the resulted reaction mixture. After the 
addition, the mixture was refluxed for 12 h. After cooling to ambient temperature, 
solid were removed by filtration and the solvent was removed under reduced pressure. 
The solid obtained was recrystallized from ethanol to yield 3.34 g (84%) of 2.8 as 
light yellow solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison with 
literature.
28
 
1
H NMR (400 MHz, CDCl3) δ 7.92 (dd, J = 9.0, 2.5 Hz, 1H), 7.73 (d, J = 
2.5 Hz, 1H), 6.88 (d, J = 9.0 Hz, 1H), 4.83 (s, 2H), 4.80 (s, 2H), 3.82 (s, 3H), 3.81 (s, 
11 
 
3H). 
13
C NMR (101 MHz, CDCl3) δ 168.5, 168.3, 153.2, 147.6, 142.4, 118.9 113.2, 
110.1, 66.4, 66.2, 52.7, 52.6; MS (m/z): [M + Na]
+
 calcd for C12H13NO8Na, 322.0; 
found, 322.1. 
2,2'-((4-Nitro-1,2-phenylene)bis(oxy))diacetic acid (2.9): Compound 2.9 was 
prepared using similar methods to those described by Gansow and coworkers.
27
  
Dowex 50WX8 (hydrogen form, 200–400 mesh, 0.22 g) was added into a mixture of 
2.8 (2.02 g, 6.75 mmol) in H2O (130 mL). The reaction mixture was heated at reflux 
for 20 h then filtered while hot. The yellow filtrate was cooled to ambient temperature 
to yield 1.59 g (87%) of 2.9 as white solid. 
1
H- and 
13
C-NMR spectra
 
were assigned 
by comparison with literature.
27
 
1
H NMR (400 MHz, DMSO-d6) δ 13.19 (brs, 2H), 
7.89 (dd, J = 9.0, 2.6 Hz, 1H), 7.69 (d, J = 2.6 Hz, 1H), 7.11 (d, J = 9.1 Hz, 1H), 4.91 
(s, 2H), 4.88 (s, 2H); 
13
C NMR (101 MHz, DMSO-d6) δ 169.7, 169.4, 153.2, 147.0, 
140.8, 117.9, 112.6, 108.4, 65.3, 65.2; MS (m/z): [M − H]− calcd for C10H8NO8, 270.0; 
found, 270.1. 
5,6-(4-Nitrobenzo)-4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-2,
9-dione (2.10): Compound 2.10 was prepared using similar methods to those 
described by Gansow and coworkers.
27
 A mixture of 2.9 (1.02 g, 3.76 mmol, 1 equiv) 
in thionyl chloride (10 mL) was heated at reflux under argon for 3 h to produce a clear, 
light yellow solution. Excess thionyl chloride was removed under reduced pressure to 
yield a light yellow solid. Next, a 500 mL three neck flask equipped with two 
dropping funnels was evacuated and filled with argon. Then 150 mL anhydrous 
toluene was added to the three neck flask. The solution was cooled to 0 °C. After that, 
12 
 
to one dropping funnel was added a solution of the above light yellow solid in a 
mixture of anhydrous toluene (20 mL) and anhydrous CH2Cl2 (20 mL). To the other 
dropping funnel was added a solution of triethylamine (1.09 g, 10.8 mmol) and 
1,4,10,13-tetraoxa-7,16-diazacyclooctadecane (0.940 g, 3.58 mmol, 0.95 equiv) in a 
mixture of anhydrous toluene (30 mL) and anhydrous CH2Cl2 (10 mL). The two 
solutions were added dropwise simultaneously to the three neck flask while stirring. 
After the additions, the turbid light yellow mixture was stirred at ambient temperature 
for 24 h. The resulting solid was filtered, and solvents were removed under reduced 
pressure to produce a yellow solid that was purified using silica gel chromatography 
(20:1 CH2Cl2/CH3OH) to yield 1.29 g (72%) of 2.10 as light yellow fluffy solid. 
1
H- 
and 
13
C-NMR spectra
 
were assigned by comparison with literature.
29
 
1
H NMR (400 
MHz, CDCl3) δ 7.82 (dd, J = 8.9, 2.6 Hz, 1H), 7.77 (d, J = 2.6 Hz, 1H), 7.01 (d, J = 
8.9 Hz, 1H), 5.63 (d, J = 15.0 Hz, 1H), 5.47 (d, J = 15.0 Hz, 1H), 4.80 (dd, J = 17.4, 
15.0 Hz, 2H), 4.44–4.20 (m, 2H), 3.99–3.41 (m, 18H), 3.34–3.12 (m, 2H), 2.88–2.71 
(m, 2H); 
13
C NMR (101 MHz, CDCl3) δ 168.70 ,154.0, 148.2, 142.1, 118.5, 117.0, 
112.0, 71.5, 71.33, 71.31, 71.2, 69.8, 69.5, 69.2, 68.9, 67.9, 67.3, 49.6, 49.5, 49.2, 
49.0; MS (m/z): [M + H]
+
 calcd for C22H32N3O10, 498.2; found, 498.3; TLC: Rf = 0.25 
(20:1 CH2Cl2/CH3OH). 
5,6-(4-Nitrobenzo)-4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane 
(2.11): Compound 2.11 was prepared using similar methods to those described by 
Gansow and coworkers.
27
 Compound 2.10 (1.17 g, 2.34 mmol, 1 equiv) was dissolved 
in anhydrous tetrahydrofuran (THF) (10 mL) under an argon atmosphere. The 
13 
 
solution was cooled 0 °C. Next, BH3 (1 M in THF, 11.0 mL, 4.7 equiv) was added at a 
speed of 30 mL/h using a syringe pump. After the addition, the solution was heated at 
reflux for 24 h. The reaction was cooled to ambient temperature, and water was added 
dropwise to destroy the excess borane. Hydrochloric acid (6 M, 11.0 mL) was added, 
and the mixture was heated at refluxed for 12 h. Ammonium hydroxide (28% NH3 in 
H2O, 10 mL) was added to adjust the pH of the solution to 9. Solvents were removed 
under reduced pressure, and the residue was dissolved in CH2Cl2 and washed with 
H2O. The organic layer was collected, and the solvent was removed under reduced 
pressure. The crude product was purified using silica gel chromatography (20:1 
CH2Cl2/CH3OH) to yield 0.891 g (81%) of 2.11 as yellow fluffy solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison with literature.
30
 
1
H NMR (400 MHz, 
CD3CN) δ 7.95 (dd, J = 9.0, 2.6 Hz, 1H), 7.83 (d, J = 2.6 Hz, 1H), 7.16 (d, J = 9.0 Hz, 
1H), 4.30 (dd, J = 9.1, 4.0 Hz, 4H), 3.68–3.46 (m, 12H), 3.44–3.32 (m, 4H), 2.85–
2.77 (m, 4H), 2.75–2.55 (m, 8H); 13C NMR (101 MHz, CD3CN) δ 153.1, 147.2, 142.6, 
118.9, 112.8, 108.5, 68.7, 68.2, 67.2, 66.8, 53.3, 53.1, 53.0; MS (m/z): [M + H]
+
 calcd 
for C22H36N3O8, 470.3; found, 470.3; TLC: Rf = 0.11 (20:1 CH2Cl2/CH3OH). 
5,6-(4-(3-(3,5-Dicarboxyphenyl)thioureido)benzo)-4,7,13,16,21,24-hexaoxa-1,10-d
iazabicyclo[8.8.8]hexacosane (2.4): A solution of 2.11 (0.612 g, 1.30 mmol, 1 equiv) 
in CH3OH (40 mL) was degassed and back filled with Ar. To the solution was added 
10% Pd/C (0.0666 g, 0.0626 mmol) quickly. The resulting mixture was hydrogenated 
using a hydrogen balloon and heating at reflux for 12h. The Pd/C was removed using 
a 0.2 μm hydrophobic filter, and the filtrate was concentrated under reduced pressure 
14 
 
to produce a pink paste. The pink paste was then dissolved in a mixture of acetone (50 
mL) and CH2Cl2 (20 mL). To the resulting solution was added 
5-isothiocyanatoisophthalic acid (2.7) (0.295 g, 1.32 mmol, 1 equiv). The resulting 
white cloudy mixture was stirred under Ar at ambient temperature for 24 h. The 
reaction mixture was filtered, and the resulting off-white solid was washed with 
acetone (10 mL) and CH2Cl2 (10 mL). The solid was then dissolved in a minimum 
amount of boiling water, and a white solid precipitated upon cooling to ambient 
temperature. The solid was collected and dried under vacuum to yield 0.329 g (38%) 
of 2.4 as a white solid. 
1
H- and 
13
C-NMR spectra
 
were assigned using distortionless 
enhancement polarization transfer (DEPT), gradient correlation spectroscopy 
(GCOSY), gradient heteronuclear multiple quantum correlation (GHMQC), and 
gradient heteronuclear multiple bond correlation (GHMBC) experiments. 
1
H NMR 
(400 MHz, D2O) δ 8.13 (s, CH, 1H), 7.84 (s, CH, 2H), 7.05–6.86 (m, CH, 3H), 4.35 
(d, J = 24.9 Hz, CH2, 4H), 3.92–3.35 (m, CH2, 28H); 
13
C NMR (101 MHz, D2O–
DMSO-d6) δ 181.2, 174.7, 147.6, 146.4, 139.4, 139.0, 133.1, 129.5 (CH), 128.6 (CH), 
120.7 (CH), 113.8 (CH), 112.3 (CH), 71.40 (CH2), 71.38 (CH2), 65.7 (CH2), 63.4 
(CH2), 57.4 (CH2), 57.3 (CH2), 57.0 (CH2); HRESIMS (m/z): [M + Na]
+
 calcd for 
C31H42N4O10SNa, 685.2519; found, 685.2517. 
5,6-(4-(3-(3,5-Dimethoxycarbonylphenyl)thioureido)benzo)-4,7,13,16,21,24-hexao
xa-1,10-diazabicyclo[8.8.8]hexacosane (2.6): A solution of 2.11 (0.128 g, 0.273 
mmol, 1 equiv) in CH3OH (30 mL) was degassed and back filled with Ar. To the 
resulted solution was quickly added 10% Pd/C (0.0202 g, 0.0190 mmol). The 
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resulting mixture was hydrogenated using a hydrogen balloon and heating at reflux 
for 12 h. The Pd/C was removed using a 0.2 μm hydrophobic filter, and the filtrate 
was concentrated under reduced pressure to produce a pink paste. The pink paste was 
dissolved in CH2Cl2 (10 mL) under Ar. To the resulting solution was added a solution 
of dimethyl 5-isothiocyanatoisophthalate (0.0801 g, 0.319 mmol, 1.2 equiv) in 
CH2Cl2 (5 mL) dropwise. The reaction was stirred at ambient temperature under Ar 
for 24 h. The solvent was removed under reduced pressure, and the resulting solid was 
purified using silica gel chromatography (15:1 CH2Cl2/CH3OH) to yield 0.109 g (58%) 
of 2.6 as light yellow solid. 
1
H- and 
13
C-NMR spectra
 
were assigned using DEPT, 
GCOSY, GHMQC, and GHMB experiments. 
1
H NMR (400 MHz, CD2Cl2) δ 11.45 (s, 
NH, 1H), 11.40 (s, NH, 1H), 8.60 (d, J = 1.5 Hz, CH, 2H), 8.34 (t, J = 1.5 Hz, CH, 
1H), 7.68 (d, J = 2.3 Hz, CH, 1H), 7.25 (dd, J = 8.7, 2.3 Hz, CH, 1H), 6.87 (d, J = 8.7 
Hz, CH, 1H), 4.21 (t, J = 4.7 Hz, CH2, 2H), 4.13 (t, J = 4.7 Hz, CH2, 2H), 3.92 (s, 
CH3, 6H), 3.64–3.38 (m, CH2, 16H), 2.87 (t, J = 4.7 Hz, CH2, 2H), 2.80 (t, J = 4.7 Hz, 
CH2, 2H), 2.73– 2.57 (m, CH2, 8H); 
13
C NMR (101 MHz, CD2Cl2) δ 181.2, 166.5, 
145.5, 143.6, 141.3, 134.7, 130.9, 128.8 (CH), 126.1 (CH), 117.1 (CH), 112.6 (CH), 
110.9 (CH), 68.8 (CH2), 68.7 (CH2), 68.2 (CH2), 68.1 (CH2), 65.9 (CH2), 65.8 (CH2), 
53.7 (CH2), 53.4 (CH2), 53.2 (CH2), 52.6 (CH3); HRESIMS (m/z): [M + Na]
+
 calcd 
for C33H46N4O10SNa, 713.2832; found, 713.2829; TLC: Rf = 0.11 (15:1 
CH2Cl2/CH3OH). 
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2.3 
1
H- and 
13
C-NMR Spectra of 2.4 and 2.6–2.11 
 
Figure 2.2 
1
H-NMR spectrum of 2.4. 
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Figure 2.3 
13
C-NMR spectrum of 2.4. 
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 Figure 2.4 
1
H-NMR spectrum of 2.6. 
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Figure 2.5 
13
C-NMR spectrum of 2.6. 
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Figure 2.6 
1
H-NMR spectrum of 2.7. 
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Figure 2.7 
13
C-NMR spectrum of 2.7. 
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Figure 2.8 
1
H-NMR spectrum of 2.8. 
 
23 
 
 
Figure 2.9 
13
C-NMR spectrum of 2.8. 
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Figure 2.10 
1
H-NMR spectrum of 2.9. 
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Figure 2.11 
13
C-NMR spectrum of 2.9. 
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Figure 2.12 
1
H-NMR spectrum of 2.10. 
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Figure 2.13 
13
C-NMR spectrum of 2.10. 
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Figure 2.14 
1
H-NMR spectrum of 2.11. 
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Figure 2.15 
13
C-NMR spectrum of 2.11.  
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Chapter 3: Synthesis of Azacryptand Ligands for Luminescence Studies of Eu
2+
 
3.1 Introduction 
The relative stability of half-filled 4f orbitals compared to other electronic 
configurations enables europium to access a divalent oxidation state (Eu
2+
) in addition 
to its common trivalent oxidation state. In its first excited state, Eu
2+
 has the electron 
configuration of 4f
6
5d
1
. Unlike the 4f orbitals, which are shielded from the outside by 
the full 5s and 5p orbitals, the 5d orbitals are readily influenced by ligands. This 
access to d orbitals enables Eu
2+
 to behave differently from Eu
3+ 
with respect to 
luminescence.
11
 Eu
2+
-containing complexes have characteristic broad emissions (390–
580 nm) in addition to sharp emission bands between 354 and 376 nm that are similar 
to those observed in Eu
3+
.
10
 In protic solvents, macrocyclic ligands are needed to 
prevent quenching of the luminescence of Eu
2+
 by solvent molecules.
11
 However, the 
study and application of coordination compounds of Eu
2+
 are largely limited by its 
tendency to be oxidized to Eu
3+
. The Allen research group has used modified 
cryptands (Figure 3.1) to stabilize the Eu
2+
.
16
 Their study suggests that further 
stabilization of Eu
2+
 is possible.  
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Figure 3.1 Unfunctionalized cryptand 3.1 and modified cryptands 3.2–3.6 
Eu
2+
 is soft and electron-rich. Therefore, substitution of the oxygen atoms in the 
cryptand ring with the softer nitrogen atoms and introducing electron-withdrawing 
phenyl groups near the donors were two strategies pursued by me to further stabilize 
Eu
2+
. Based on these ideas the azacryptand ligands 3.7 and 3.8 were the targets of my 
research (Figure 3.2).  
 
Figure 3.2 Structures of ligands 3.7 and 3.8.  
Ligand 3.7 was prepared according to the published procedures.
31,32
 The 
synthetic procedures are shown in Scheme 3.1. Briefly, tris(2-aminoethyl)amine and 
glyoxal solution were reacted in the presence of triethylamine to give the imine 
32 
 
intermediate. This imine was reduced by NaBH4 to give the azacryptand as a white 
solid. 
Scheme 3.1 Synthesis of azacryptand 3.7. 
 
The proposed synthetic procedures for compound 3.8 are shown in Scheme 3.2. I 
synthesized compound 3.10 according to the literature procedures.
33
 Starting from 
compound 3.10, initially I tried the similar method that was used in the synthesis of 
compound 3.7, but the reaction didn‟t work. Then I used oxalyl chloride, and reaction 
afforded compound 3.11 in a very low yield (5%). Due to the low solubility of 
compound 3.11, only high resolution electrospray ionization mass spectrometry 
(HRESIMS) was performed for characterization of this compound.  
Scheme 3.2 Proposed synthetic procedures for azacryptand 3.8. 
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Reduction of compound 3.11 with LiAlH4 did not afford a clean reaction. In the 
mass spectrometry of the reaction mixture, I observed the product peak as well as 
peaks from many partially reduced products. Increasing the reaction time and the 
amount of LiAlH4 did not help. Reduction with BH3-THF afforded less partially 
reduced products in the mass spectrometry. 
3.2 Experimental Procedures 
3.2.1 Materials 
Commercially available chemicals were of reagent-grade purity or better and 
were used as received unless otherwise noted. Triethylamine was dried over calcium 
hydride and distilled under an argon atmosphere. Water was purified using a 
PURELAB Ultra Mk2 purification system. Flash chromatography was performed 
using silica gel 60, 230–400 mesh. Analytical thin-layer chromatography (TLC) was 
carried out on TLC plates precoated with silica gel 60 F254 (250 μm layer thickness). 
TLC plates visualization was accomplished with a UV lamp or by charring with 
potassium permanganate stain (1.5 g KMnO4, 10 g K2CO3, 2.5 mL 5% w/v aqueous 
NaOH, and 150 mL H2O). 
3.2.2 Characterization 
1
H- and 
13
C-NMR spectra were recorded at ambient temperature on a Varian 
Unity 400 spectrometer (400 MHz for 
1
H and 101 MHz for 
13
C). Chemical shifts were 
referenced to solvent residual signals (CDCl3: 
1H δ 7.26 ppm, 13C δ 77.16; D2O: 
1H δ 
4.79, 
13
C was referenced to 5% DMSO-d6 added δ 39.52;). 
1
H-NMR data are assumed 
to be first order, and the apparent multiplicities are reported as follows: „„s‟‟ = singlet, 
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„„d‟‟ = doublet, “t” = triplet, “m” = multiplet, and „„br‟‟ = broad. High resolution 
electrospray ionization mass spectra (HRESIMS) were recorded on a Waters LCT 
Premiere Xe TOF mass spectrometer. Low resolution mass spectra (MS) of known 
compounds were recorded on a Shimadzu LCMS-2010EV mass spectrometer to 
confirm identity. 
3.2.3 Synthesis 
1,4,7,10,13,16,21,24-Octaazabicyclo[8.8.8]hexacosane (3.7): Compound 3.7 was 
prepared by following literature procedures.
31,32
 A solution of tris(2-aminoethyl)amine 
(1.95 g, 13.3 mmol, 1 equiv) and triethylamine (5.0 mL) in i-PrOH (90 mL) was 
cooled to –78 °C , and to the resulting solution was added a solution of glyoxal (40% 
in H2O; 2.91 g, 20.0 mmol, 1.5 equiv) in i-PrOH (50 mL) dropwise while stirring. 
After the addition, the reaction mixture was warmed to ambient temperature. Solvent 
was removed under reduced pressure to produce a yellowish brown solid that was 
extracted with CHCl3 (100 mL). Solvent was removed under reduced pressure to 
produce a yellow solid that was dissolved in CH3OH (80 mL). To the resulting 
solution was added NaBH4 (2.58 g, 68.2 mmol). The resulting mixture was stirred at 
ambient temperature under Ar for 4 h. Solvent was removed under reduced pressure to 
produce a white powder that was recrystallized twice from water to yield 0.702 g 
(28%) of 3.7 as white solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison 
with the literature.
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1
H NMR (400 MHz, D2O) δ 2.76 (s, 12H), 2.69 (brs, 12H), 2.51 
(brs, 12H); 
13
C NMR (101 MHz, D2O–DMSO-d6) δ 53.7, 50.4, 47.7; [M + H]
+
 calcd 
for C18H43N8, 371.4; found, 371.4. 
35 
 
Tris(2-nitrophenyl)amine (3.9): Compound 3.9 was prepared by following a 
literature procedure.
33
 A mixture of 2-nitroaniline (1.99 g, 14.4 mmol, 1 equiv), 
2-fluoro-nitrobenzene (8.16 g, 57.8 mmol, 4 equiv), and K2CO3 (12.2 g, 88.3 mmol, 6 
equiv) in dimethyl sulfoxide (DMSO) (12 mL) was stirred under Ar at 145 °C for 84 h. 
The reaction mixture was cooled to ambient temperature and diluted with water (200 
mL). The resulting mixture was sonicated for 10 min and filtered using a medium frit 
to produce a brown solid. The brown solid was dissolved in CH3OH (200 mL), and 
the resulting mixture was heated at reflux for 20 min. The mixture was filtered while 
hot, and the resulting solid was washed with CH3OH (3 × 20 mL, ambient 
temperature) and dried under vacuum to produce 3.61 g (66%) of 3.9 as yellow solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison with the literature.
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1
H NMR 
(400 MHz, CDCl3) δ 7.83 (d, J = 8.2, 3H), 7.53 (t, J = 7.8, 3H), 7.30 (t, J = 7.8, 3H), 
7.21 (d, J = 8.2, 3H); 
13
C NMR (101 MHz, CDCl3) δ 144.0, 138.9, 134.0, 128.5, 
126.4, 126.2; [M + Na]
+
 calcd for C18H12N4O6Na, 403.1; found, 403.1. 
Tris(2-aminophenyl)amine (3.10): Compound 3.10 was prepared by following a 
literature procedure.
33
 To a solution of 3.9 (1.47 g, 3.87 mmol) in THF (100 mL) 
under argon was quickly added Pd/C (10%, 0.236 g, 0.222 mmol). The resulting 
reaction mixture was degassed under vacuum and back filled with H2 using a H2 
balloon. The reaction mixture was stirred at ambient temperature for 48 h, and then 
filtered through a pad of celite on a medium frit. The filtrate was concentrated under 
reduced pressure to produce an off-white solid. This solid was washed with diethyl 
ether (3 × 15 mL) and dried under vacuum to yield 0.842 g (75%) of 3.10 as an 
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off-white solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison with the 
literature.
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1
H NMR (400 MHz, CDCl3) δ 6.99 (t, J = 7.6 Hz, 3H), 6.91 (d, J = 7.7 Hz, 
3H), 6.77–6.63 (m, 6H), 3.47 (brs, 6H); 13C NMR (101 MHz, CDCl3) δ 141.4, 132.5, 
125.8, 125.7, 119.0, 116.6; [M + H]
+
 calcd for C18H19N4, 291.2; found, 291.2. 
2,3,8,9,11,12,17,18,19,20,25,26-hexabenzo-1,4,7,10,13,16,21,24-Octaazabicyclo[8.8
.8]hexacosane-5,614,15,22,23-hexaone (3.11): Compound 3.11 was synthesized 
using similar methods to those described in the literature.
34
 A solution of compound 
3.10 (0.810 g, 2.79 mmol, 1 equiv) in THF (80 mL) was added dropwise to oxalyl 
chloride (12.0 g, 94.5 mmol) at 0 °C under Ar. After the addition, the reaction mixture 
was stirred at ambient temperature for 12 h. The excess oxalyl chloride was removed 
under reduced pressure to produce a yellow solid that was dissolved in THF (100 mL). 
The resulting solution and a solution of triethylamine (1.67 g, 16.5 mmol) and 
compound 3.10 (0.732 g, 2.52 mmol, 0.9 equiv) in THF (100 mL) were added 
simultaneously to THF (200 mL) at 0 °C. After the additions, the resulting turbid 
mixture was stirred at ambient temperature for 24 h. The resulting solid was removed 
by filtration, and solvents were removed under reduced pressure to produce brown 
solid that was purified using silica gel chromatography (CH2Cl2) to yield 0.0900 g 
(4.8%) of 3.11 as white solid. HRESIMS (m/z): [M + Na]
+
 calcd for C42H30N8O6Na, 
765.2186; found, 765.2168; TLC: Rf = 0.08 (CH2Cl2). 
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3.3 
1
H- and 
13
C-NMR Spectra of compounds 3.7, 3.9, and 3.10. 
 
 
Figure 3.3 
1
H-NMR spectrum of 3.7. 
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Figure 3.4 
13
C-NMR spectrum of 3.7. 
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Figure 3.5 
1
H-NMR spectrum of 3.9. 
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Figure 3.6 
13
C-NMR spectrum of 3.9. 
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Figure 3.7 
1
H-NMR spectrum of 3.10. 
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Figure 3.8 
13
C-NMR spectrum of 3.10.  
43 
 
Chapter 4: Synthesis of Tetraoxolene-Bridged Cryptand Ligands for Magnetic 
Studies of Divalent Lanthanides 
4.1 Introduction 
Divalent europium (Eu
2+
) has a large magnetic moment that is partially due to its 
7 half-filled 4f orbitals. The interesting magnetic properties of Eu
2+
 make it a suitable 
candidate for fabricating novel magnetic materials. Among the interesting magnetic 
materials there is a class of compounds that were discovered twenty years ago known 
as single molecule magnets (SMMs).
35
 These compounds possess energy barriers that 
are large enough to allow retention of magnetization upon removal from an external 
magnetic field. Early studies on SMMs were dominated by 3d transition metals, 
especially Mn
3+
.
36
 However, the development of SMMs was hindered by the inability 
to increase total spin S and axial anisotropy D simultaneously.
37
 Recently, there has 
been an increasing agreement that single ion anisotropy is crucial to obtain large 
energy barrier SMMs.
38
 Thus, considerable attention has been paid to lanthanides and 
actinides whose single-ion anisotropies are unrivalled in the periodic table.
37
 A third 
way to further maximize the energy barrier besides increasing S and D is to increase 
exchange coupling by incorporating a radical bridge between multiple metals in the 
complex. Long, Evans, and coworkers have synthesized a series of N2
3−
, bipyrimidyl, 
and 2,3,5,6-tetra(2-pyridyl)pyrazine) radical-bridged di-lanthanide complexes.
39
 
These complexes show single molecule magnet properties. Based on these ideas, we 
designed ligand 4.1 (Scheme 4.1), in which two cryptands are bridged by tetraoxolene, 
which is a multi-electron redox-active ligand. The cryptand can form complexes with 
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divalent lanthanides such as Eu
2+
, Sm
2+
, and Yb
2+
, which are less studied compared to 
trivalent lanthanides. The proposed synthetic procedures for ligand 4.1 are shown in 
Scheme 4.1. Dihydroxybenzoquinone was reduced using tin in concentrated 
hydrochloric acid,
40
 and reacted with methyl bromoacetate to give ester 4.2. It was 
hydrolyzed using DOWEX to give the corresponding acid 4.3. Reaction of this acid 
with oxalyl chloride afforded the acid chloride which was further reacted with 
aza-crown ether to give the corresponding amide. In the mass spectrometry I observed 
the peak of the amide, but I was not able to purify it using silica gel chromatography. 
Scheme 4.1 Proposed synthetic procedures for ligand 4.1 
4.2 Experimental Procedures 
4.2.1 Materials 
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Commercially available chemicals were of reagent-grade purity or better and 
were used as received unless otherwise noted. Water was purified using a PURELAB 
Ultra Mk2 purification system.  
4.2.2 Characterization 
1
H- and 
13
C-NMR spectra were recorded at ambient temperature on a Varian 
Unity 400 spectrometer (400 MHz for 
1
H and 101 MHz for 
13
C). Chemical shifts were 
referenced to solvent residual signals (CDCl3: 
1H δ 7.26 ppm, 13C δ 77.16; DMSO-d6: 
1H δ 2.50, 13C δ 39.52). 1H-NMR data are assumed to be first order, and the apparent 
multiplicities are reported as follows: „„s‟‟ = singlet and „„br‟‟ = broad. Italicized 
elements are those that are responsible for the shifts. High resolution electrospray 
ionization mass spectra (HRESIMS) were recorded on a Waters LCT Premiere Xe 
TOF mass spectrometer. Low resolution mass spectra (MS) of known compounds 
were recorded on a Shimadzu LCMS-2010EV mass spectrometer. 
4.2.3 Synthesis 
Tetramethyl 2,2',2'',2'''-(benzene-1,2,4,5-tetrayltetrakis(oxy))tetraacetate (4.2): 
To a stirred mixture of 2,5-dihydroxy-1,4-benzoquinone (1.98 g, 14.1 mmol, 1 equiv) 
in HCl (36%, aqueous, 50 mL) was slowly added granular tin metal (2.12 g, 17.8 
mmol, 1.3 equiv).
40
 The reaction mixture was heated at reflux for 1 h then filtered 
while hot. The filtrate was cooled to 0 °C to produce an off-white solid that was 
crystallized from tetrahydrofuran to yield 0.776 g of a white solid. The solid was 
dissolved in acetone (20 mL), and added dropwise into a stirred mixture of K2CO3 
(7.80 g, 56.4 mmol) and methyl bromoacetate (8.56 g, 56.0 mmol) in acetone (130 
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mL). The reaction mixture was stirred at reflux under Ar for 24 h. After cooling to 
ambient temperature, solids were removed by filtration, and the solvent was removed 
under reduced pressure to produce an orange oil. The oil was dissolved in ethyl 
acetate (50 mL), washed with water (3 × 50 mL) and dried over anhydrous Na2SO4. 
The solvent was removed under reduced pressure to produce a yellow solid that was 
recrystallized twice from ethanol to yield 0.508 g (8.4%) of 4.2 as white solid. 
1
H- 
and 
13
C-NMR spectra
 
were assigned using DEPT, GCOSY, GHMQC, and GHMBC 
experiments. 
1
H NMR (400 MHz, CDCl3) δ 6.66 (s, CH, 2H), 4.65 (s, CH2, 8H), 3.78 
(s, CH3, 12H); 
13
C NMR (101 MHz, CDCl3) δ 169.5, 143.6, 107.8 (CH), 67.8 (CH2), 
52.3 (CH3); HRESIMS (m/z): [M + Na]
+
 calcd for C18H22O12Na, 453.1009; found, 
453.1009. 
2,2',2'',2'''-(Benzene-1,2,4,5-tetrayltetrakis(oxy))tetraacetic acid (4.3): Dowex 
50WX8 (hydrogen form, 200–400 mesh, 0.22 g) was added to a mixture of 4.2 (1.05 g, 
2.44 mmol) in H2O (100 mL). The reaction mixture was heated at reflux for 24 h then 
filtered while hot. The filtrate was cooled to ambient temperature to yield 0.847 g 
(93%) of 4.3 as white solid. 
1
H- and 
13
C-NMR spectra
 
were assigned by comparison 
with published assignments.
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1
H NMR (400 MHz, DMSO-d6) δ 12.90 (brs, 4H), 6.70 
(s, 2H), 4.62 (s, 8H); 
13
C NMR (101 MHz, DMSO-d6) δ 170.4, 142.0, 105.3, 66.4; 
MS (m/z): [M + Na]
+
 calcd for C14H14O12Na, 397.0; found, 397.0 . 
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4.3 
1
H- and 
13
C-NMR Spectra of compounds 4.2 and 4.3. 
 Figure 4.1 1H-NMR spectrum of 4.2. 
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Figure 4.2 
13
C-NMR spectrum of 4.2. 
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Figure 4.3 
1
H-NMR spectrum of 4.3. 
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Figure 4.4 
13
C-NMR spectrum of 4.3.  
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Chapter 5: Summary and Future Outlook 
5.1 Summary and Future Outlook 
Coordination chemistry is one of the most important fields in modern inorganic 
chemistry. Ligand synthesis using organic techniques plays an important role in 
coordination chemistry. This thesis describes my efforts to synthesize different 
cryptands for Eu
2+
-containing complexes. Subsequent metalation with Eu
2+
 will 
produce Eu
2+
-containing cryptates. Cyclic voltammetry experiment can be performed 
to study the oxidative stability of these complexes. 
As with the ligand for MRI application, 
5,6-(4-(3-(3,5-dicarboxyphenyl)thioureido)benzo)-4,7,13,16,21,24-hexaoxa-1,10-diaz
abicyclo[8.8.8]hexacosane, a series of molecules with two carboxylic groups can be 
attached to cryptand unit through thiourea linkage. For example, the positions of two 
carboxylic groups can be changed in phenyl ring; amino acids such as aspartic acid 
and glutamic acid can also be used. 
The Allen group has studied Eu
2+
 complexes of ligand 
1,4,7,10,13,16,21,24-octaazabicyclo[8.8.8]hexacosane (aza222). It was found that this 
complex has bright yellow luminescence.
42
 Based on this result, I did a literature 
search to find ways to incorporate the aza222 ligand into polymers. Jackson and 
coworkers recently reported methods to synthesize aza222-based polymers.
43
 Thus, 
future work based on this ligand could include synthesizing Eu
2+
-containing 
aza222-based polymers, and measuring their luminescence properties.  
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In the process of synthesizing phenyl derivatives of aza222, the synthetic 
methods need to be modified to increase the yield to produce one of the intermediates 
2,3,8,9,11,12,17,18,19,20,25,26-hexabenzo-1,4,7,10,13,16,21,24-octaazabicyclo[8.8.8
]hexacosane-5,614,15,22,23-hexaone. Also, the low solubility of the intermediate in 
common organic solvents prevents further characterizations except high resolution 
electrospray ionization mass spectra. One possible solution is to grow single crystals 
by slow vaporization of its concentrated CH2Cl2 or THF solution.  
Finally, efforts are needed to synthesize the tetraoxolene bridged dicryptand 
ligand. Lower reaction yields are expected compared to the synthesis of ligand that 
has only one cryptand. In addition, functionalized tetraoxolene such as 
hydrochloranilic acid can also be used as bridging ligand. 
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Eu
2+
-containing complexes have considerable applications in synthetic chemistry, 
medical diagnosis, and materials science. However, Eu
2+
 is easily oxidized in solution 
when exposed to air. Allen and coworkers have demonstrated that Eu
2+
 can be 
stabilized by functionalized cryptands. Based on this idea, I focused my research on 
synthesizing cryptands. The progress towards synthesizing several modified cryptands 
is described in the thesis. The Eu
2+
-containing complexes of these cryptates have 
potential applications as magnetic resonance imaging contrast agents, luminescent 
materials, and magnetic materials. 
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